Dr. Regan comes to Cascade Prodrug as leading expert in tumor metabolism and cancer micro-environments, including both extracellular acidity and related hypoxia. Upon completion of his residency, he joined a group in private practice and was instrumental in growing that group, merging into the US Oncology Network and becoming Compass Oncology, the largest oncology provider group in Oregon. Dr Regan has held national leadership roles in the oncology field for over 20 years. He previously served as a National Medical Director for US Oncology for Guidelines and Clinical Pathways Development, as President of the Association of Community Cancer Centers (ACCC), and as a member of the Committee on Practice of the American Society of Hematology (ASH). He is an active member of the Clinical Practice Committee of the American Society of Medical Oncology (ASCO) and represents ASCO as an Advisor to the AMA Relative Value Update Committee.
Dr Regan received his Bachelors Degree from University of California, Berkeley and his MD from University of Southern California Medical School. He subsequently completed clinical training at Bellevue Hospital of the New York University Medical Center and Oregon Health Sciences University.